BridgeBio Pharma, Inc.BBIONASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-0.46%
↑ 99% above average
Average (30q)
-53.08%
Historical baseline
Range
High:94.98%
Low:-1293.46%
Volatility
-2615.5%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -0.46% |
| Q2 2025 | -8.65% |
| Q1 2025 | 36.83% |
| Q4 2024 | -63.57% |
| Q3 2024 | -120.59% |
| Q2 2024 | -108.59% |
| Q1 2024 | 79.06% |
| Q4 2023 | 5.00% |
| Q3 2023 | -12.10% |
| Q2 2023 | -12.66% |
| Q1 2023 | -1.86% |
| Q4 2022 | -0.18% |
| Q3 2022 | -1293.46% |
| Q2 2022 | 94.98% |
| Q1 2022 | -33.44% |
| Q4 2021 | 5.62% |
| Q3 2021 | -61.85% |
| Q2 2021 | 40.92% |
| Q1 2021 | -35.92% |
| Q4 2020 | -3.56% |
| Q3 2020 | 4.28% |
| Q2 2020 | -31.77% |
| Q1 2020 | -25.04% |
| Q4 2019 | -22.47% |
| Q3 2019 | 8.98% |
| Q2 2019 | -7.70% |
| Q1 2019 | -58.34% |
| Q4 2018 | -23.06% |
| Q3 2018 | -18.27% |
| Q2 2018 | 22.27% |
| Q1 2018 | 0.00% |